Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3-Triazolylbenzyl-aminophosphonates

Arch Pharm (Weinheim). 2016 Jan;349(1):30-41. doi: 10.1002/ardp.201500292. Epub 2015 Nov 17.

Abstract

A novel series of ribonucleosides of 1,2,3-triazolylbenzyl-aminophosphonates was synthesized through the Kabachnik-Fields reaction using I2 as catalyst followed by copper-catalyzed cycloaddition of the azide-alkyne reaction (CuAAC). All structures of the newly prepared compounds were characterized by (1) H NMR, (13) C NMR, and HRMS spectra. The structures of 2e, 2f, 3d, and 3g were further confirmed by X-ray diffraction analysis. These compounds were tested against various strains of DNA and RNA viruses; compounds 4b and 4c showed a modest inhibitory activity against respiratory syncytial virus (RSV) and compound 4h displayed modest inhibitory activity against Coxsackie virus B4.

Keywords: 1,2,3-Triazoles; Antiviral activity; Kabachnik-Fields reaction; Ribonucleosides; α-Aminophosphonates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology
  • Cell Line
  • Crystallography, X-Ray
  • DNA Viruses / drug effects
  • Humans
  • Organophosphonates / chemical synthesis
  • Organophosphonates / chemistry*
  • Organophosphonates / pharmacology
  • RNA Viruses / drug effects
  • Ribonucleosides / chemical synthesis
  • Ribonucleosides / chemistry*
  • Ribonucleosides / pharmacology
  • Structure-Activity Relationship
  • Triazoles / chemical synthesis
  • Triazoles / chemistry*
  • Triazoles / pharmacology

Substances

  • Antiviral Agents
  • Organophosphonates
  • Ribonucleosides
  • Triazoles